Identification and validation of potential key long noncoding RNAs in sorafenib-resistant hepatocellular carcinoma cells
As the first-line treatment, sorafenib has been used for advanced hepatocellular carcinoma (HCC), but the chemoresistance commonly restricts to the clinical efficiency. In this study, we intend to investigate the genome-wide expression pattern of long noncoding RNAs (lncRNAs) in sorafenib-resistant...
Main Authors: | Manya Wu, Xiaoyun Shen, Yanping Tang, Caifu Zhou, Haixia Li, Xiaoling Luo |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2020-02-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/8624.pdf |
Similar Items
-
The expression and function of long noncoding RNAs in hepatocellular carcinoma
by: Jingli Du, et al.
Published: (2023-12-01) -
Long noncoding RNAs in the initiation, progression, and metastasis of hepatocellular carcinoma
by: Johanna K. DiStefano
Published: (2017-09-01) -
Sorafenib in the treatment of advanced hepatocellular carcinoma
by: Mousa Ali
Published: (2008-01-01) -
Sorafenib in advanced hepatocellular carcinoma: current status and future perspectives
by: Hsu CH, et al.
Published: (2014-06-01) -
Fucoidan inhibits EGFR redistribution and potentiates sorafenib to overcome sorafenib-resistant hepatocellular carcinoma
by: Jialiang Luo, et al.
Published: (2022-10-01)